Global Protein Expression Market

1 INTRODUCTION OF GLOBAL PROTEIN EXPRESSION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PROTEIN EXPRESSION MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL PROTEIN EXPRESSION MARKET, BY END USER
5.1 Pharmaceutical and Biotechnology Companies
5.2 Academic Research Institutes
5.3 Contract Research Organizations
5.4 Other End Users

6 GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION
6.1 Therapeutic Applications
6.2 Industrial Applications
6.3 Research Applications

7 GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT AND SERVICES
7.1 Reagents
7.2 Expression Vectors
7.3 Competent Cells
7.4 Instruments
7.5 Services

8 GLOBAL PROTEIN EXPRESSION MARKET, BY SYSTEM TYPE
8.1 Cell-Free Expression Systems
8.2 Algal-Based Expression Systems
8.3 Yeast Expression Systems
8.3.1 K. Lactis Systems
8.3.2 Saccharomyces Systems
8.3.3 Pichia Systems
8.3.4 Other Yeast Expression Systems
8.4 Insect Cell Expression Systems
8.4.1 Baculovirus Systems
8.4.2 Other Insect Cell Systems
8.5 Mammalian Cell Expression Systems
8.5.1 Chinese Hamster Ovary Systems
8.5.2 Other Mammalian Cell Systems
8.6 Prokaryotic Expression Systems
8.6.1 Escherichia Coli Systems
8.6.2 Other Prokaryotic Expression Systems
9 GLOBAL PROTEIN EXPRESSIONMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL PROTEIN EXPRESSIONMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Thermo Fisher Scientific Inc.
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Merck KGaA
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Genscript Biotech Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Agilent Technologies, Inc.
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Takara Bio Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 Promega Corporation
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 Bio-Rad Laboratories, Inc.
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Qiagen N.V.
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Lonza Group Ltd.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Developments

11.10 New England Biolabs Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Developments

11.11 Sengenics
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Developments

11.12 Proteogenix
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Developments

11.13 Synthetic Genomics Inc.
11.13.1 Overview
11.13.2 Financial Performance
11.13.3 Product Outlook
11.13.4 Key Developments

12 Appendix
12.1 Related Reports